A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/454 (2006.01) A61K 31/4166 (2006.01) A61K 31/5377 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2531861
The present invention relates to the use of 1-ar(alk)ylimidazolin-2-ones which contain a disubstituted amine radical in the 4-position for the treatment or prevention of central nervous system disorders including depression, anxiety, movement disorders, and especially dystonia, and psychotic disorders, and especially schizophrenia and psychotic symptoms associated to other mental disorders.
La présente invention concerne l'utilisation d'1-ar(alk)ylimidazolin-2-ones contenant un radical amine disubstitué en position 4 dans le traitement ou la prévention de troubles du système nerveux central parmi lesquels figurent la dépression, l'anxiété, les troubles du mouvement, en particulier la dystonie, les troubles psychotiques, en particulier la schizophrénie, et les symptômes psychotiques associés à d'autres troubles mentaux.
Dost Rita
Langen Barbara
Luddens Hartmut
Rabe Holger
Rundfeldt Chris
Boehringer Ingelheim Vetmedica Gmbh
Elbion Ag
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Method of treating or preventing central nervous system... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or preventing central nervous system..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or preventing central nervous system... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1910308